VPTDF News and Press, VentriPoint Diagnostics Ltd From 04/23/18

(via TheNewswire) Toronto, Ontario / TheNewswire / April 23, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that it exhibited at the 20 th annual Canadian Society of Echocardiography conference which was recently ...

(via TheNewswire) Toronto, Canada / TheNewswire / March 29, 2018 - Ventripoint Diagnostics Ltd . ("Ventripoint" or the "Company") (TSXV:VPT) is pleased to announce that it has agreed to issue to Dr. George Adams, CEO of Ventripoint, 375,000 common shares of the Company in payme...

(via TheNewswire) Toronto, Ontario / TheNewswire / March 26, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce its participation in a Natural Sciences and Engineering Research Council (NSERC) Eng age grant for the developm...

(via TheNewswire) Toronto, Canada / TheNewswire / February 22, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSXV:VPT) is pleased to announce that it has been named to the 2018 TSX Venture 50, a ranking of the top performers on the TSX Ventu...

(via TheNewswire) Toronto, Canada / TheNewswire / February 21, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSXV:VPT) is pleased to announce the installation of the VMS+ whole heart analysis system at the University of Alberta Mazanko wski Alberta H...

(via TheNewswire) Toronto, Ontario / TheNewswire / February 6, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that Dr. Andriy Shmatukha has joined the Ventripoint team as software developer to advance the Ventripoint produ...

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2018) - Trading resumes in: IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are i...

(via TheNewswire) Toronto, Ontario / TheNewswire / January 17, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that it has submitted a traditional 510(k) application to the FDA's Center for Devices and Radiological Health (...

(via TheNewswire) Toronto, Canada / TheNewswire / January 10, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSXV:VPT) is pleased to announce the appointment of David McPhedran as Director of Sales for North America, effective immediately. "I am ex...

(via TheNewswire) Toronto, Ontario / TheNewswire / January 8, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that it has received the European CE Mark for the VMS+ Whole Heart Analysis System, which allows the Company ...